Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
511-525 of 2993 results
MetaStat reveals prognostic study preliminary results of MetaSite Breast test
By MDBR Staff Writer
Molecular diagnostic firm MetaStat has revealed preliminary results from a study of MetaSite Breast test in patients with ER-positive, HER2-negative early stage invasive breast cancer.
Diagnostics > In Vitro Diagnostics > News
Nestlé, AC Immune to develop diagnostic test for Alzheimer’s disease
By MDBR Staff Writer
Biomedical research institute Nestlé Institute of Health Sciences (NIHS) has entered into a research collaboration agreement with biopharmaceutical firm AC Immune to develop a diagnostic test for Alzheimer’s disease (AD).
Diagnostics > In Vitro Diagnostics > News
GenomOncology, Thomas Jefferson Hospital developing multi-assay integrated cancer profiling system
By MDBR Staff Writer
Healthcare technology firm GenomOncology, along with US-based Thomas Jefferson University Hospital, is involved in developing an interpretation and reporting system for multi-assay cancer profiling.
Diagnostics > In Vitro Diagnostics > News
Study Demonstrates T2Candida Panel is more sensitive and rapid than blood vulture at identifying invasive infections
By MDBR Staff Writer
T2 Biosystems announced that data on its T2Candida Panel was presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the International Society of Chemotherapy (ICC) joint meeting in San Diego, US.
Diagnostics > In Vitro Diagnostics > News
Transgenomic, University of Melbourne partner for MX-ICP technology
By MDBR Staff Writer
Australia’s University of Melbourne has received a license from biotechnology firm Transgenomic to use its Multiplexed ICE COLD-PCR (MX-ICP) technology for several research and clinical applications.
Diagnostics > In Vitro Diagnostics > News
WuXi NextCODE to provide genome testing services to China’s Fudan Children's Hospital
By MDBR Staff Writer
Precision medicine firm WuXi NextCODE has entered into an agreement with Shanghai-based Children's Hospital of Fudan University (CHFU) to provide genomic testing capabilities for rare diseases in China.
Diagnostics > In Vitro Diagnostics > News
ERBA Diagnostics Mannheim acquires Lumora
By MDBR Staff Writer
ERBA Diagnostics Mannheim, a global in vitro diagnostics company, announced it has completed the acquisition of Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial markets.
Diagnostics > In Vitro Diagnostics > News
Biocept secures agreements with Stratose and Galaxy Health Network for its blood-based oncology diagnostic assays
By MDBR Staff Writer
Biocept, a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces additional agreements with preferred provider organizations (PPOs).
Diagnostics > In Vitro Diagnostics > News
Pathway Genomics launches liquid biopsy test to detect cancer-associated mutations in high-risk patients
By MDBR Staff Writer
Pathway Genomics, a global precision medical diagnostics company, announced the launch of CancerIntercept, its first liquid biopsy, a non-invasive screening test designed for early cancer detection and monitoring, for as low as $299.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific obtains IVDD CE mark approval for three new products
By MDBR Staff Writer
Thermo Fisher Scientific has obtained in vitro diagnostics device (IVDD) CE mark approval for its Prelude MD HPLC, Endura MD mass spectrometer and ClinQuan MD software.
Diagnostics > In Vitro Diagnostics > News
Meridian’s Bioline introduces new EPIK miRNA Panel Assays
By MDBR Staff Writer
Meridian Bioscience's wholly-owned subsidiary Bioline has introduced new EPIK miRNA Panel Assays across the globe.
Diagnostics > In Vitro Diagnostics > News
Focus obtains FDA approval to add genital swab claim to Simplexa HSV 1 & 2 Direct test
By MDBR Staff Writer
Focus Diagnostics, a subsidiary of Quest Diagnostics, has obtained 510(k) approval from the US Food and Drug Administration (FDA) to add the genital swab claim to its Simplexa HSV 1 & 2 Direct molecular test on the integrated cycler.
Diagnostics > In Vitro Diagnostics > News
Binding Site introduces special protein analyzer Optilite in North America
By MDBR Staff Writer
Special protein diagnostics provider Binding Site has introduced its fully-automated special protein analyzer Optilite in North America.
Diagnostics > In Vitro Diagnostics > News
NOWDiagnostics acquires Canada's ZBx
By MDBR Staff Writer
NOWDiagnostics recently completed its acquisition of ZBx Corporation of Canada, a move that brings the company closer to its vision of a world where people have greater access to information concerning their health.
Diagnostics > In Vitro Diagnostics > News
Thermo Fisher Scientific introduces two new NGS systems
By MDBR Staff Writer
Thermo Fisher Scientific has launched two new next-generation sequencing (NGS) systems, which provide comprehensive solution to simplify targeted sequencing.
Diagnostics > In Vitro Diagnostics > News
511-525 of 2993 results